Serum creatine-kinase-BB and brain damage in high-risk newborn infants. Preliminary study with a new method for CK-BB...

Area of Science:

• Neonatal neurology
• Biochemical markers
• Neurodevelopmental disorders

Background:

• Hypoxic conditions in newborns can lead to central nervous system disease.
• Creatine kinase-BB (CK-BB) is an enzyme implicated in brain injury.
• Early identification of neonatal brain damage is crucial for timely intervention.

Purpose of the Study:

• To investigate the correlation between serial CK-BB activity measurements and early neurologic outcomes in high-risk newborns.
• To assess the utility of a sensitive CK-BB assay in predicting long-term neurologic abnormalities.

Main Methods:

• Serial measurements of CK-BB activity were performed on 54 high-risk newborns during the first three postnatal days.
• A novel, highly sensitive method was employed for CK-BB activity estimation.
• Enzymatic values were correlated with neurologic assessments at five months of age.

Main Results:

• A significant correlation was observed between elevated CK-BB activity and the presence of persistent neurologic abnormalities (P < .05).
• The sensitive CK-BB assay demonstrated good predictive value for adverse neurologic outcomes.
• Early postnatal CK-BB levels served as a potential indicator of neonatal brain damage.

Conclusions:

• Early postnatal determination of CK-BB activity can serve as a valuable indicator of neonatal brain damage.
• This biochemical marker aids in identifying infants at risk for persistent neurologic deficits.
• The findings support the use of CK-BB measurements in neonatal intensive care for risk stratification.